Back to Results
First PageMeta Content
Prosthetics / Pharmaceutical industry / Thrombogenicity / Thrombus / Medical device / Pre-clinical development / Ventricular assist device / Food and Drug Administration / Heparin / Medicine / Hematology / Implants


Welcome and Overview of the Current FDA Approach to Thrombogenicity Evaluation Jennifer Goode, BS, Biomedical Engineer FDA Office of Device Evaluation Division of Cardiovascular Devices
Add to Reading List

Open Document

File Size: 113,57 KB

Share Result on Facebook
UPDATE